Literature DB >> 19498170

Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.

Srinivasa Subramaniam1, Katherine M Sixt, Roxanne Barrow, Solomon H Snyder.   

Abstract

Huntington's disease (HD) is caused by a polyglutamine repeat in the protein huntingtin (Htt) with mutant Htt (mHtt) expressed throughout the body and similarly in all brain regions. Yet, HD neuropathology is largely restricted to the corpus striatum. We report that the small guanine nucleotide-binding protein Rhes, which is localized very selectively to the striatum, binds physiologically to mHtt. Using cultured cells, we found Rhes induces sumoylation of mHtt, which leads to cytotoxicity. Thus, Rhes-mHtt interactions can account for the localized neuropathology of HD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498170      PMCID: PMC2745286          DOI: 10.1126/science.1172871

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

Review 1.  The selective vulnerability of nerve cells in Huntington's disease.

Authors:  K A Sieradzan; D M Mann
Journal:  Neuropathol Appl Neurobiol       Date:  2001-02       Impact factor: 8.090

2.  The polycomb protein Pc2 is a SUMO E3.

Authors:  Michael H Kagey; Tiffany A Melhuish; David Wotton
Journal:  Cell       Date:  2003-04-04       Impact factor: 41.582

3.  The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors.

Authors:  Pierfrancesco Vargiu; Ricardo De Abajo; Juan Antonio Garcia-Ranea; Alfonso Valencia; Pilar Santisteban; Piero Crespo; Juan Bernal
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

4.  Neurological abnormalities in a knock-in mouse model of Huntington's disease.

Authors:  C H Lin; S Tallaksen-Greene; W M Chien; J A Cearley; W S Jackson; A B Crouse; S Ren; X J Li; R L Albin; P J Detloff
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

5.  Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.

Authors:  M S Levine; G J Klapstein; A Koppel; E Gruen; C Cepeda; M E Vargas; E S Jokel; E M Carpenter; H Zanjani; R S Hurst; A Efstratiadis; S Zeitlin; M F Chesselet
Journal:  J Neurosci Res       Date:  1999-11-15       Impact factor: 4.164

6.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

7.  Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON.

Authors:  M Fang; S R Jaffrey; A Sawa; K Ye; X Luo; S H Snyder
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

8.  Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.

Authors:  V C Wheeler; J K White; C A Gutekunst; V Vrbanac; M Weaver; X J Li; S H Li; H Yi; J P Vonsattel; J F Gusella; S Hersch; W Auerbach; A L Joyner; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

9.  Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death.

Authors:  B Gong; M C Y Lim; J Wanderer; A Wyttenbach; A J Morton
Journal:  Brain Res Bull       Date:  2007-09-17       Impact factor: 4.077

10.  Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

Authors:  F Trettel; D Rigamonti; P Hilditch-Maguire; V C Wheeler; A H Sharp; F Persichetti; E Cattaneo; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

View more
  149 in total

1.  Striatum specific protein, Rhes regulates AKT pathway.

Authors:  Sookhee Bang; Catherine Steenstra; Sangwon F Kim
Journal:  Neurosci Lett       Date:  2012-06-06       Impact factor: 3.046

Review 2.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

3.  The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease.

Authors:  Yan Wang; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

4.  Rheb Inhibits Protein Synthesis by Activating the PERK-eIF2α Signaling Cascade.

Authors:  Richa Tyagi; Neelam Shahani; Lindsay Gorgen; Max Ferretti; William Pryor; Po Yu Chen; Supriya Swarnkar; Paul F Worley; Katrin Karbstein; Solomon H Snyder; Srinivasa Subramaniam
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

Review 5.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

6.  Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.

Authors:  Robert G Mealer; Alexandra J Murray; Neelam Shahani; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

7.  Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.

Authors:  L M Harrison; S H Muller; D Spano
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

8.  Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

Authors:  Ian H Kratter; Hengameh Zahed; Alice Lau; Andrey S Tsvetkov; Aaron C Daub; Kurt F Weiberth; Xiaofeng Gu; Frédéric Saudou; Sandrine Humbert; X William Yang; Alex Osmand; Joan S Steffan; Eliezer Masliah; Steven Finkbeiner
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

9.  Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice.

Authors:  P Matthew Joyner; Ronni M Matheke; Lindsey M Smith; Robert H Cichewicz
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

10.  Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity.

Authors:  Yong Chen; Reas S Khan; Alyssa Cwanger; Ying Song; Catherine Steenstra; Sookhee Bang; Jaime H Cheah; Joshua Dunaief; Kenneth S Shindler; Solomon H Snyder; Sangwon F Kim
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.